Ultragenyx Pharmaceutical (RARE) FCF Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 1,960.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,960.00 |
| Dec 31, 2025 | 3,689.00 |
| Sep 30, 2025 | 4,431.00 |
| Jun 30, 2025 | 1,751.00 |
| Mar 31, 2025 | 5,788.00 |
| Dec 31, 2024 | 3,614.00 |
| Sep 30, 2024 | 4,595.00 |
| Jun 30, 2024 | 4,613.00 |
| Mar 31, 2024 | 41.00 |
| Dec 31, 2023 | 5,174.00 |
| Sep 30, 2023 | -7,685.00 |
| Jun 30, 2023 | -23,935.00 |
| Mar 31, 2023 | 13,570.00 |
| Dec 31, 2022 | 14,968.00 |
| Sep 30, 2022 | 26,029.00 |
| Jun 30, 2022 | 30,601.00 |
| Mar 31, 2022 | 36,586.00 |
| Dec 31, 2021 | 26,639.00 |
| Sep 30, 2021 | 49,845.00 |
| Jun 30, 2021 | 50,718.00 |
| Mar 31, 2021 | 66,566.00 |
| Dec 31, 2020 | 373,299.00 |
| Sep 30, 2020 | 3.18 Mn |
| Dec 31, 2019 | 76.59 Mn |
| Sep 30, 2019 | 2.82 Mn |
| Jun 30, 2019 | 26.25 Mn |